Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey B Ulmer

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Expert Opinion on Biological Therapy|February 19, 2002
Toward the development of better vaccine adjuvantsJeffrey B Ulmer
Idrugs : the Investigational Drugs Journal|July 17, 2003
The future of vaccines--cancer meets infectious diseases: cancer vaccines and emerging vaccines. 10-13 April 2003, Semmering, AustriaJeffrey B Ulmer
Idrugs : the Investigational Drugs Journal|May 11, 2005
DNA vaccines forum: how to enhance DNA vaccines safety and potency?Jeffrey B Ulmer
Idrugs : the Investigational Drugs Journal|October 4, 2006
Novel vaccines: bridging research, development and production - CHI's Inaugural ConferenceJeffrey B Ulmer
Expert Opinion on Biological Therapy|July 23, 2004
Enhancement of vaccine potency through improved deliveryJeffrey B Ulmer
Idrugs : the Investigational Drugs Journal|May 10, 2008
DNA Vaccines 2008--A marcus evans Forum Bridging the Gap Between Technology and ApplicationJeffrey B Ulmer
Vaccine|July 12, 2002
Influenza DNA vaccinesJeffrey B Ulmer
Current Protocols in Human Genetics|April 23, 2008
DNA vaccinationJeffrey B Ulmer, Rino Rappuoli
Current Opinion in Immunology|April 29, 2011
Promising cutting-edge technologies and tools to accelerate the discovery and development of new vaccinesJeffrey B Ulmer, Marcelo B Sztein
Current Opinion in Immunology|May 31, 2016
Recent innovations in mRNA vaccinesJeffrey B Ulmer, Andrew J Geall
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Expert Opinion on Biological Therapy|February 19, 2002
Toward the development of better vaccine adjuvantsJeffrey B Ulmer
Idrugs : the Investigational Drugs Journal|July 17, 2003
The future of vaccines--cancer meets infectious diseases: cancer vaccines and emerging vaccines. 10-13 April 2003, Semmering, AustriaJeffrey B Ulmer
Idrugs : the Investigational Drugs Journal|May 11, 2005
DNA vaccines forum: how to enhance DNA vaccines safety and potency?Jeffrey B Ulmer
Idrugs : the Investigational Drugs Journal|October 4, 2006
Novel vaccines: bridging research, development and production - CHI's Inaugural ConferenceJeffrey B Ulmer
Expert Opinion on Biological Therapy|July 23, 2004
Enhancement of vaccine potency through improved deliveryJeffrey B Ulmer
Idrugs : the Investigational Drugs Journal|May 10, 2008
DNA Vaccines 2008--A marcus evans Forum Bridging the Gap Between Technology and ApplicationJeffrey B Ulmer
Vaccine|July 12, 2002
Influenza DNA vaccinesJeffrey B Ulmer
Current Protocols in Human Genetics|April 23, 2008
DNA vaccinationJeffrey B Ulmer, Rino Rappuoli
Current Opinion in Immunology|April 29, 2011
Promising cutting-edge technologies and tools to accelerate the discovery and development of new vaccinesJeffrey B Ulmer, Marcelo B Sztein
Current Opinion in Immunology|May 31, 2016
Recent innovations in mRNA vaccinesJeffrey B Ulmer, Andrew J Geall
Pageof 9